Revenio Group Oyj REG1V.HE

Name: Revenio Group Oyj
SKU: REG1V.HE
Price: 22.35 EUR
Availability: InStock

‎€‎22.350-0.05(-0.22%)(1D)

• Delayed prices by CBOE EU • in EUR

Invest in Revenio Group Oyj
Today

Create an eToro account to buy REG1V.HE stock on a secure, user-friendly, multi-asset trading platform.

Revenio Group Oyj REG1V.HE

Buy REG1V.HE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Chagee Holdings Limited

‎$‎11.90

Canadian Imperial Bank of Commerce

Huaneng Power International Inc (HK)

MAX

*Past performance is not an indication of future results

Jump to:

About REG1V.HE >
How to Buy? >
Top Guides >

The Revenio Group Oyj share price is stable this week.

The Revenio Group Oyj share price today is ‎€‎22.350, reflecting a ‎-0.22‎% change over the last 24 hours and ‎-0.22‎% over the past week. The current market capitalization of REG1V.HE is ‎€‎594.58M with an average volume in the last three months of 23059.29. The stock has a P/E ratio of 32.14 and a dividend yield of 0.02%. With the stock’s beta sitting at 0.98

REG1V.HE Key Metrics

Market Cap

‎€‎594.58M

Day’s Range

‎€‎22.116 - ‎€‎22.466

52W Range

‎€‎20 - ‎€‎25.162

Average Volume (3M)

23059.29

Price-Earnings Ratio

32.14

Revenue

‎€‎109M

Dividend (Yield)

‎€‎0.4 (0.02%)

Prev Close

‎€‎22.35

EPS

‎€‎0.7

Beta

0.98

How can I buy Revenio Group Oyj stocks?

To purchase Revenio Group Oyj:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Revenio Group Oyj (REG1V.HE) page and place an order to buy Revenio Group Oyj.

Buy REG1V.HE

Looking for more information? Check out our guide on Academy.

What Is Revenio Group Oyj?

Revenio Group Oyj is a Finnish healthcare technology company specialising in medical devices for eye care. Its primary aim is to enable early detection and management of various eye diseases, including glaucoma and macular degeneration. It serves healthcare professionals globally.

Operating within the medical technology sector, Revenio Group Oyj focuses on developing and commercialising advanced ophthalmological diagnostic devices and related services. Its work is intended to improve patient outcomes and quality of life by preventing vision loss and blindness.

Explore REG1V.HE share prices and other stocks on eToro.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

Jouni Erik Toijala, MBA

Employees

241

Founded

2001

Vantaa, Uusimaa, FI

Med Tech

Helsinki

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2025

Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.

Stock Trading And Investing For Beginners

New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.

AI Stocks Poised for Growth in 2025

Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Revenio Group Oyj
Today

Create an eToro account to buy REG1V.HE stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Revenio Group Oyj stock?

The current price of REG1V.HE is ‎€‎22.350.

What are analysts’ forecasts for Revenio Group Oyj?

Analysts offer forecasts for Revenio Group Oyj based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Revenio Group Oyj?

The market capitalisation of Revenio Group Oyj is ‎€‎594.58M

Daily Movers

Explore the biggest stocks movers on the market.